Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperuricemia
Phenotype C0376545|hematological malignancies
Sentences 2
PubMedID- 20818444 Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies.
PubMedID- 26161019 Therefore, febuxostat and rasburicase may be good alternatives for the treatment of hyperuricemia, particularly in patients with hematological malignancies who are likely to undergo chemotherapy.

Page: 1